Fexofenadine HCl
- Product NDC
- 53002-1409
- 11-digit product format
- 530021409
- Labeler code
- 53002
- Product ID
- 53002-1409_ac265116-25b6-42f1-9582-8b9099eb075a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Fexofenadine HCl
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA204507
- Marketing category
- ANDA
- Marketing start
- 2015-09-16
- Marketing end
- 0000-00-00
- Substance
- FEXOFENADINE HYDROCHLORIDE
- Active strength
- 180 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53002-1409-1 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |
| 53002-1409-2 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |
| 53002-1409-3 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |
| 53002-1409-5 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |
| 53002-1409-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |
| 53002-1409-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |
| 53002-1409-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |
| 53002-1409-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cc46-f424-e053-dadaa90a57ce | 7d8be3b6-90d1-4262-bc5d-6915a936d94a |